Nasdaq · Common stock
SpyGlass Pharma (SGP)
$29.91 +$1.43 (+5.02%)
- Day’s range
- $28.09–$30.37
- Volume
- 89,399
SGP price history
SGP closed at $29.91 on Oct. 26, 2026. Over the past year, its daily close ranged from $17.56 on June 16, 2026 to $29.91 on Oct. 26, 2026.
Data table: SGP daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $29.91 |
| Oct. 23, 2026 | $28.48 |
| Oct. 22, 2026 | $28.22 |
| Oct. 21, 2026 | $27.71 |
| Oct. 20, 2026 | $26.16 |
| Oct. 19, 2026 | $24.60 |
| Oct. 16, 2026 | $24.00 |
| Oct. 15, 2026 | $24.72 |
| Oct. 14, 2026 | $23.69 |
| Oct. 13, 2026 | $23.92 |
| Oct. 12, 2026 | $24.86 |
| Oct. 9, 2026 | $24.92 |
| Oct. 8, 2026 | $24.62 |
| Oct. 7, 2026 | $23.90 |
| Oct. 6, 2026 | $24.78 |
| Oct. 5, 2026 | $25.59 |
| Oct. 2, 2026 | $24.92 |
| Oct. 1, 2026 | $26.50 |
| Sept. 30, 2026 | $26.00 |
| Sept. 29, 2026 | $25.44 |
| Sept. 28, 2026 | $25.98 |
| Sept. 25, 2026 | $27.07 |
| Sept. 24, 2026 | $27.65 |
| Sept. 23, 2026 | $28.16 |
| Sept. 22, 2026 | $28.69 |
| Sept. 21, 2026 | $27.96 |
| Sept. 18, 2026 | $29.08 |
| Sept. 17, 2026 | $29.33 |
| Sept. 16, 2026 | $28.60 |
| Sept. 15, 2026 | $28.96 |
| Sept. 14, 2026 | $28.66 |
| Sept. 11, 2026 | $27.52 |
| Sept. 10, 2026 | $27.31 |
| Sept. 9, 2026 | $27.50 |
| Sept. 8, 2026 | $28.92 |
| Sept. 4, 2026 | $28.94 |
| Sept. 3, 2026 | $28.99 |
| Sept. 2, 2026 | $28.28 |
| Sept. 1, 2026 | $26.86 |
| Aug. 31, 2026 | $26.10 |
| Aug. 28, 2026 | $26.42 |
| Aug. 27, 2026 | $26.93 |
| Aug. 26, 2026 | $26.64 |
| Aug. 25, 2026 | $26.60 |
| Aug. 24, 2026 | $26.26 |
| Aug. 21, 2026 | $26.51 |
| Aug. 20, 2026 | $26.23 |
| Aug. 19, 2026 | $27.23 |
| Aug. 18, 2026 | $25.84 |
| Aug. 17, 2026 | $25.78 |
| Aug. 14, 2026 | $26.20 |
| Aug. 13, 2026 | $25.17 |
| Aug. 12, 2026 | $25.27 |
| Aug. 11, 2026 | $24.85 |
| Aug. 10, 2026 | $25.16 |
| Aug. 7, 2026 | $25.31 |
| Aug. 6, 2026 | $24.75 |
| Aug. 5, 2026 | $23.68 |
| Aug. 4, 2026 | $24.11 |
| Aug. 3, 2026 | $22.68 |
| July 31, 2026 | $22.53 |
| July 30, 2026 | $22.72 |
| July 29, 2026 | $21.91 |
| July 28, 2026 | $21.62 |
| July 27, 2026 | $20.82 |
| July 24, 2026 | $20.49 |
| July 23, 2026 | $20.88 |
| July 22, 2026 | $20.54 |
| July 21, 2026 | $20.27 |
| July 20, 2026 | $20.02 |
| July 17, 2026 | $19.77 |
| July 16, 2026 | $20.76 |
| July 15, 2026 | $20.60 |
| July 14, 2026 | $19.99 |
| July 13, 2026 | $19.90 |
| July 10, 2026 | $22.52 |
| July 9, 2026 | $20.07 |
| July 8, 2026 | $20.46 |
| July 7, 2026 | $19.52 |
| July 6, 2026 | $19.09 |
| July 2, 2026 | $19.15 |
| July 1, 2026 | $19.47 |
| June 30, 2026 | $22.26 |
| June 29, 2026 | $21.65 |
| June 26, 2026 | $21.18 |
| June 25, 2026 | $18.81 |
| June 24, 2026 | $19.55 |
| June 23, 2026 | $19.67 |
| June 22, 2026 | $19.34 |
| June 18, 2026 | $18.70 |
| June 17, 2026 | $18.20 |
| June 16, 2026 | $17.56 |
| June 15, 2026 | $18.94 |
| June 12, 2026 | $18.44 |
| June 11, 2026 | $18.09 |
| June 10, 2026 | $17.97 |
| June 9, 2026 | $18.19 |
| June 8, 2026 | $18.74 |
| June 5, 2026 | $18.78 |
| June 4, 2026 | $19.47 |
| June 3, 2026 | $18.56 |
| June 2, 2026 | $18.36 |
| June 1, 2026 | $18.32 |
| May 29, 2026 | $19.26 |
| May 28, 2026 | $19.84 |
| May 27, 2026 | $20.17 |
| May 26, 2026 | $20.62 |
| May 22, 2026 | $20.84 |
| May 21, 2026 | $22.05 |
| May 20, 2026 | $21.89 |
| May 19, 2026 | $21.20 |
| May 18, 2026 | $22.24 |
| May 15, 2026 | $23.21 |
| May 14, 2026 | $24.27 |
| May 13, 2026 | $23.82 |
| May 12, 2026 | $24.14 |
| May 11, 2026 | $23.76 |
| May 8, 2026 | $23.41 |
| May 7, 2026 | $25.39 |
| May 6, 2026 | $25.06 |
| May 5, 2026 | $24.41 |
| May 4, 2026 | $24.41 |
| May 1, 2026 | $23.98 |
| April 30, 2026 | $22.94 |
| April 29, 2026 | $22.13 |
| April 28, 2026 | $23.00 |
| April 27, 2026 | $23.65 |
| April 24, 2026 | $23.52 |
| April 23, 2026 | $23.63 |
| April 22, 2026 | $24.49 |
| April 21, 2026 | $24.45 |
| April 20, 2026 | $24.52 |
| April 17, 2026 | $24.94 |
| April 16, 2026 | $25.03 |
| April 15, 2026 | $24.73 |
| April 14, 2026 | $24.52 |
| April 13, 2026 | $23.87 |
| April 10, 2026 | $20.75 |
| April 9, 2026 | $21.22 |
| April 8, 2026 | $22.22 |
| April 7, 2026 | $21.07 |
| April 6, 2026 | $22.65 |
| April 2, 2026 | $22.46 |
| April 1, 2026 | $24.44 |
| March 31, 2026 | $25.91 |
| March 30, 2026 | $23.37 |
| March 27, 2026 | $22.61 |
| March 26, 2026 | $25.20 |
| March 25, 2026 | $25.22 |
| March 24, 2026 | $23.74 |
| March 23, 2026 | $26.35 |
| March 20, 2026 | $26.00 |
| March 19, 2026 | $25.71 |
| March 18, 2026 | $26.80 |
| March 17, 2026 | $27.20 |
| March 16, 2026 | $27.10 |
| March 13, 2026 | $26.55 |
| March 12, 2026 | $26.42 |
| March 11, 2026 | $27.10 |
| March 10, 2026 | $26.82 |
| March 9, 2026 | $27.12 |
| March 6, 2026 | $26.68 |
| March 5, 2026 | $26.42 |
| March 4, 2026 | $26.68 |
| March 3, 2026 | $26.75 |
| March 2, 2026 | $26.73 |
| Feb. 27, 2026 | $28.00 |
| Feb. 26, 2026 | $28.35 |
| Feb. 25, 2026 | $29.13 |
| Feb. 24, 2026 | $29.29 |
| Feb. 23, 2026 | $29.35 |
| Feb. 20, 2026 | $29.32 |
| Feb. 19, 2026 | $29.68 |
| Feb. 18, 2026 | $28.50 |
| Feb. 17, 2026 | $27.69 |
| Feb. 13, 2026 | $28.22 |
| Feb. 12, 2026 | $27.50 |
| Feb. 11, 2026 | $27.55 |
| Feb. 10, 2026 | $27.83 |
| Feb. 9, 2026 | $26.18 |
| Feb. 6, 2026 | $26.40 |
Key figures
- Average daily volume
- 100,237Past 3 months
- Market value
- $1.00B
- Dividend yield
- —
Price change
- 1 month
- +10.49%
- 3 months
- +45.97%
What Wall Street says about SGP
In the past 90 days, Wall Street firms published 3 rating or price-target actions on SGP: 1 new rating and 2 reiterated ratings.
| Action | Rating | |||
|---|---|---|---|---|
| HC Wainwright & Co. | Reiterates | Buy | $37 | |
| HC Wainwright & Co. | Reiterates | Buy | $37 | |
| Raymond James | Initiates coverage | Outperform | $39 |
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About SpyGlass Pharma, Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
- Headquarters
- Irvine, Calif.
- Employees
- 65
- Listed
- Feb. 6, 2026
- Sector
- Health care
- Industry
- Surgical & medical instruments & apparatus
In WallStreetDigest editions
No WallStreetDigest article about SGP is on the site yet.